HYALUAL Xela Rederm 1.8% (1x2ml)
The lowest price of the product zł209.00 in day 13.01.2026
HYALUAL Xela Rederm 1.8% is a sterile, biocompatible Class III medical device in the form of a solution for intradermal implantation, utilizing advanced redermalization technology. The preparation is based on a synergistic combination of non-cross-linked hyaluronic acid at an increased concentration (18 mg/ml) and sodium succinate (16 mg/ml). The device is intended for the intensive regeneration of tissues with pronounced signs of aging, directly influencing the energy potential of dermal cells and the restructuring of the extracellular matrix (ECM).
Mechanism of Action
-
cellular respiration intensification (sodium succinate): active sodium succinate optimizes the citric acid (krebs) cycle in the mitochondria, increasing atp production and accelerating the synthesis of structural proteins
-
advanced hydro-restructuring: hyaluronic acid (1.8%) provides long-lasting iso-osmotic hydration, creating a stable scaffolding for fibroblasts and supporting their migration to areas requiring repair
-
oxidative stress neutralization: the preparation acts as a potent antioxidant, protecting membrane lipids and cellular dna from degradation caused by free radicals
-
neocollagenesis and elastogenesis stimulation: the synergy of ingredients induces the remodeling of collagen fibers, resulting in the mechanical smoothing of deep wrinkles and an improvement in the skin's biomechanical parameters (firmness, elasticity)
-
trophicity and tone regulation: improvement of tissue microcirculation and metabolic processes promotes the lightening of hyperpigmentation and the restoration of physiological skin homeostasis
Indications and Intended Use
The device is intended for intradermal implantation by authorized medical personnel to:
-
comprehensive rejuvenation of mature skin: dedicated to patients aged 35 and over with visible loss of density and suppleness
-
correction of established wrinkles and furrows: reduction of the depth and length of lines on the face, neck, and décolletage
-
revitalization of sensitive areas: correction of the skin structure around the eyes and the lip contour
-
non-surgical tissue lifting: improving tension and the facial oval by densifying the dermal structures
Application Areas
-
face (including periorbital and perioral zones)
-
neck
-
décolletage
Composition
-
hyaluronic acid concentration: 1.8% (18 mg/ml)
-
sodium succinate concentration: 1.6% (16 mg/ml)
Technical Information and Protocol
-
form: 1 ml or 2 ml glass pre-filled syringe (depending on variant)
-
application site: dermis (intradermal implantation)
-
recovery time: estimated time for papule resolution and healing is up to 3 days for the face and 5 to 6 days for the neck and décolletage
-
injection technique: intradermal (papular or retrograde linear)
-
package contents: 1 pre-filled syringe, 2 sterile 30G x 13 mm needles
|
PRE-FILLED SYRINGE |
||
|
The product may only be used by professionals. By making a purchase, you declare that you are a doctor or cosmetologist trained in aesthetic medicine. |
||